STOCK TITAN

Exact Sciences schedules second quarter 2021 earnings call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Exact Sciences Corp. (Nasdaq: EXAS) will release its second-quarter 2021 financial results on July 28, 2021, after U.S. markets close. Following the release, a webcast and conference call will be held at 5 p.m. EDT to discuss the financial results and business progress. Interested parties can access the live webcast at Exact Sciences' website. The company is recognized for its cancer screening and diagnostic tests, including Cologuard and Oncotype tests, and continues to invest in its product pipeline to enhance cancer diagnosis and treatment.

Positive
  • Continuing investment in product pipeline to support cancer diagnosis and treatment.
Negative
  • None.

MADISON, Wis., July 8, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company plans to release its second quarter 2021 financial results after the close of the U.S. financial markets on July 28, 2021. Following the release, company management will host a webcast and conference call at 5 p.m. EDT to discuss financial results and business progress.

Second quarter 2021 webcast & conference call details

Date:

Wednesday, July 28, 2021


Time:

5 p.m. EDT


Webcast:

The live webcast can be accessed at www.exactsciences.com


Telephone:

Domestic callers, dial 833-235-7650 



International callers, dial +1 647-788-4901



Access code for both domestic and international callers: 3969691


An archive of the webcast will be available at www.exactsciences.com. A replay of the conference call will be available by calling 800-585-8367 domestically or 416-621-4642 internationally. The access code for the replay of the call is 3969691. The webcast, conference call and replay are open to all interested parties.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter answers to give people the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype tests, Exact Sciences is investing in its product pipeline to support patients throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.

Contact:
Megan Jones
Exact Sciences Corp.
meganjones@exactsciences.com
608-535-8815

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-schedules-second-quarter-2021-earnings-call-301327561.html

SOURCE EXACT SCIENCES CORP

FAQ

When will Exact Sciences release its second quarter 2021 earnings?

Exact Sciences will release its second quarter 2021 earnings on July 28, 2021.

What time is the Exact Sciences earnings call?

The Exact Sciences earnings call is scheduled for 5 p.m. EDT on July 28, 2021.

How can I access the Exact Sciences earnings call?

The earnings call can be accessed via webcast on Exact Sciences' website.

What is the ticker symbol for Exact Sciences?

Exact Sciences' ticker symbol is EXAS.

What are Exact Sciences' key products?

Exact Sciences is known for its Cologuard and Oncotype tests for cancer screening and diagnostics.

Exact Sciences Corp

NASDAQ:EXAS

EXAS Rankings

EXAS Latest News

EXAS Stock Data

9.16B
185.08M
1%
99.1%
8.41%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
MADISON